from: Boshoff et al (2004). The transcriptional responses of Mycobacterium tuberculosis to inhibitors of metabolism. J Biol Chem.

Gene Expression Profile for Rv1865c/-

LFCtreatmentdescriptionclass of inhibitor

0.698

Amikacinug/mL Amikacintranslation

0.398

Cap5-10ug/mL Capreomycintranslation

0.179

Rox10-50 ug/mL Roxithromycintranslation

0.326

SM2-5 ug/mL Streptomycintranslation

-0.174

Tet5-10 ug/mL Tetracyclinetranslation

0.472

Rif0.2-5ug/mL Rifampicintranscription

-0.005

Rifp0.1-0.5ug/mL Rifapentinetranscription

-0.316

Min_med__succinate_Minimal medium with succinate as sole carbon source as compared to growth in 7H9/ADC/Tween/glycerolstarvation

-0.371

CCCP10-50 uM Carbonyl cyanide 3-chlorophenylhydrazonerespiration

-0.327

CPZ10-50 ug/mL Chlorpromazinerespiration

-1.132

Clofazimine10-13 ug/mL Clofaziminerespiration

-0.853

Clotrimazole10-24 ug/mL Clotrimazole (azole drug)respiration

0.949

DCCD20-100 uM Dicyclohexylcarbodiimiderespiration

-1.093

DNP"0.5-2.5 mM 2,4-Dinitrophenol"respiration

-0.824

DTT"1-2 mM 1,4-Dithio-DL-threitol"respiration

0.645

Econazole10-24 ug/mL Econazole (azole drug)respiration

0.922

GSNO_CFZ0.1 mM S-Nitrosoglutathione + 5 ug/mL Clofaziminerespiration

-1.445

GSNO_CPZ0.1 mM S-Nitrosoglutathione + 20-25 ug/mL Chlorpromazinerespiration

-2.155

GSNO_KCN0.1mM S-Nitrosoglutathione + 5ug/mL potassium cyaniderespiration

0.043

GSNO_menadione0.1 mM S-Nitrosoglutathione + 6-10 ug/mL menadionerespiration

-0.837

KCN5-20 ug/mL Potassium cyaniderespiration

0.827

NaN30.2-2 mM Sodium aziderespiration

-0.569

Nigericin50 uM Nigericinrespiration

0.524

TRC10-150 ug/mL Triclosanrespiration

-1.801

TRZ10-25 ug/mL Thioridazinerespiration

-1.363

Valinomycin0.5-10 uM Valinomycinrespiration

0.000

ZnSO42 mM ZnSO4respiration

-1.117

menadione6-10 ug/mL Menadionerespiration

-0.004

Ascididemin_Nat_prod4-9 ug/mL Organic extract of Eudistoma amplumironLimitation

-0.109

Deferoxamine150-250 uM Deferoxamine mesylateironLimitation

-0.310

Dipyridyl"100-200 uM 2,2'-Bipyridyl"ironLimitation

0.410

GSNO0.02-0.1mM S-NitrosoglutathionedosRassociated

-1.221

NRP_1Non-replicating persistence stage 1dosRassociated

0.083

Amp0.2mg/mL AmpicillincellWall

0.746

Cephalexin20-100 ug/mL CephalexincellWall

-0.292

Cerulenin0.32-5 ug/mL CerulenincellWall

0.788

DIPED5-100 ug/mL DiisopropylethylenediaminecellWall

0.278

EMB10-20 ug/mL EthambutolcellWall

0.018

Eta12-40 ug/mL EthionamidecellWall

0.063

INH0.2-0.4 ug/mL IsoniazidcellWall

0.101

TLM0.1-0.2 mg/mL ThiolactomycincellWall

-1.039

PalmitateMinimal medium with palmitate as sole C-source as compared to minimal medium with glucose as sole CsourcecarbonSource

-0.681

SuccinateMinimal medium with succinate as sole C-source as compared to minimal medium with glucose as sole CsourcecarbonSource

0.455

BZA0.12 mg/mL BenzamidearomaticAmides

0.496

Nam0.12 - 1.2 mg/mL NicotinamidearomaticAmides

0.195

PZA0.12-1.2 mg/mL PyrazinamidearomaticAmides

0.343

H2O24 mM hydrogen peroxideDNAdamaging

-0.072

Levo10 ug/mL LevofloxacinDNAdamaging

0.364

Mtm0.1-0.2 ug/mL Mitomycin CDNAdamaging

0.475

Novobiocin10 ug/mL NovobiocinDNAdamaging

0.450

Oflox5-10 ug/mL OfloxacinDNAdamaging

0.521

UVUV-irradiationDNAdamaging

-1.193

ARP41-4 ug/mL Antitubercular compound ARP4?

-0.374

Antimycin12.5-50 ug/mL Antimycin A?

-1.175

DTNB"1-2 mM 5,5'-Dithiobis(2-nitrobenzoic acid)"?

-0.525

PA_110-50 ug/mL Antitubercular compound PA-1?

-0.599

PA_2110-50 ug/mL Antitubercular compound PA-21?

-0.311

PA8240.2-2 ug/mL PA-824?

-0.132

Procept_677620-30 ug/mL Antitubercular compound Procept 6776?

0.202

Procept_67785-40 ug/mL Antitubercular compound Procept 6778?

-0.877

Verapamil50 uM Verapamil?

-0.898

mercaptoethanol2 mM 2-Mercaptoethanol?

-1.392

methoxatin10-20 ug/mL Methoxatin?